Engineered Phage Matrix Stiffness-Modulating Osteogenic Differentiation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Hee-Book | - |
dc.contributor.author | Kang, Jeong-In | - |
dc.contributor.author | Chung, Woo Jae | - |
dc.contributor.author | Lee, Do Hoon | - |
dc.contributor.author | Lee, Byung Yang | - |
dc.contributor.author | Lee, Seung-Wuk | - |
dc.contributor.author | Yoo, So Young | - |
dc.date.accessioned | 2021-09-02T14:59:37Z | - |
dc.date.available | 2021-09-02T14:59:37Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-02-07 | - |
dc.identifier.issn | 1944-8244 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/77372 | - |
dc.description.abstract | Herein, we demonstrate an engineered phage mediated rmatrix for osteogenic differentiation with controlled stiffness by cross-linking the engineered, phage displaying Arg-Gly-Asp (RGD) and His-Pro-Gln (HPQ) with various Concentrations of streptavidin or polymer, poly(diallyldirnethylammonium)chltiride (PDDA). Osteogenic gene expressions showed that they were specifically increased when MC3T3 cells were cultured, on the stiffer phage matrix than the softer one. Our phage matrixes can be easily functionalized using chernical/gerietic engineering and-Used as a stem cell tissue matrix stiffness platform for modulating differential cell expansion and differentiation. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.subject | STEM-CELL DIFFERENTIATION | - |
dc.subject | SUBSTRATE STIFFNESS | - |
dc.subject | M13 BACTERIOPHAGE | - |
dc.subject | EXTRACELLULAR-MATRIX | - |
dc.subject | DISPLAY LIBRARIES | - |
dc.subject | PEPTIDE LIGANDS | - |
dc.subject | HPQ SEQUENCE | - |
dc.subject | BINDING | - |
dc.subject | STREPTAVIDIN | - |
dc.subject | FATE | - |
dc.title | Engineered Phage Matrix Stiffness-Modulating Osteogenic Differentiation | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Byung Yang | - |
dc.identifier.doi | 10.1021/acsami.7b17871 | - |
dc.identifier.scopusid | 2-s2.0-85041894832 | - |
dc.identifier.wosid | 000424851600002 | - |
dc.identifier.bibliographicCitation | ACS APPLIED MATERIALS & INTERFACES, v.10, no.5, pp.4349 - 4358 | - |
dc.relation.isPartOf | ACS APPLIED MATERIALS & INTERFACES | - |
dc.citation.title | ACS APPLIED MATERIALS & INTERFACES | - |
dc.citation.volume | 10 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 4349 | - |
dc.citation.endPage | 4358 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Multidisciplinary | - |
dc.subject.keywordPlus | STEM-CELL DIFFERENTIATION | - |
dc.subject.keywordPlus | SUBSTRATE STIFFNESS | - |
dc.subject.keywordPlus | M13 BACTERIOPHAGE | - |
dc.subject.keywordPlus | EXTRACELLULAR-MATRIX | - |
dc.subject.keywordPlus | DISPLAY LIBRARIES | - |
dc.subject.keywordPlus | PEPTIDE LIGANDS | - |
dc.subject.keywordPlus | HPQ SEQUENCE | - |
dc.subject.keywordPlus | BINDING | - |
dc.subject.keywordPlus | STREPTAVIDIN | - |
dc.subject.keywordPlus | FATE | - |
dc.subject.keywordAuthor | phage | - |
dc.subject.keywordAuthor | matrix | - |
dc.subject.keywordAuthor | stiffness | - |
dc.subject.keywordAuthor | osteogenic | - |
dc.subject.keywordAuthor | differentiation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.